Role of C/EBP-α in Adriamycin-induced Podocyte Injury

Overview

Journal Sci Rep

Specialty Science

Date 2016 Sep 21

PMID 27644413

Citations 10

Authors

Fang Zhong

Weiming Wang

Kyung Lee

John Cijiang He

Nan Chen

Affiliations

Soon will be listed here.

Abstract

Podocytes are terminally differentiated epithelial cells in the kidney glomeruli that act as a key component of the glomerular filtration barrier. Although the inciting injury to the podocyte may vary between various glomerular diseases, the inevitable consequence of podocyte injury results in their loss, leading to progressive kidney disease. Here, we report that the expression of CCAAT/enhancer binding protein-α (C/EBP-α), a transcription factor known to interact with and activate PPAR-γ and NF-κB, is suppressed in the glomerular cells, particularly in podocytes, in human kidneys with focal segmental glomerulosclerosis. Genetic ablation of C/EBP-α in podocytes resulted in increased proteinuria, increased podocyte foot process effacement, and to decreased podocyte number in the setting of Adriamycin (ADR)-induced nephropathy. Overexpression of C/EBP-α in human podocytes in vitro led to an inhibition of MCP-1 and IL-6 expression in response to TNF-α and IL-1β treatments. Conversely, augmented production of MCP-1 and IL-6 was observed in the glomeruli of C/EBP-α knockout mice and was associated increased infiltration of macrophages in vivo. Together, our data suggest that C/EBP-α mediates anti-inflammatory effects in podocytes to confer protection against podocyte injury and loss that may contribute to worsening glomerulosclerosis.

Citing Articles

SA4503 Mitigates Adriamycin-Induced Nephropathy via Sigma-1 Receptor in Animal and Cell-Based Models.

Tagashira H, Chida S, Bhuiyan M, Fukunaga K, Numata T Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005987 PMC: 11858467. DOI: 10.3390/ph18020172.

ATP dynamics as a predictor of future podocyte structure and function after acute ischemic kidney injury in female mice.

Takahashi M, Yamamoto S, Yamamoto S, Okubo A, Nakagawa Y, Kuwahara K Nat Commun. 2024; 15(1):9977.

PMID: 39578451 PMC: 11584722. DOI: 10.1038/s41467-024-54222-0.

C/EBPα-mediated ACSL4-dependent ferroptosis exacerbates tubular injury in diabetic kidney disease.

Xia Z, Wei Z, Li X, Liu Y, Gu X, Tong J Cell Death Discov. 2024; 10(1):448.

PMID: 39443466 PMC: 11499655. DOI: 10.1038/s41420-024-02179-w.

Podocyte senescence: from molecular mechanisms to therapeutics.

Zhao Q, Huang Y, Fu N, Cui C, Peng X, Kang H Ren Fail. 2024; 46(2):2398712.

PMID: 39248407 PMC: 11385655. DOI: 10.1080/0886022X.2024.2398712.

CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding.

Wang L, Feng J, Deng Y, Yang Q, Wei Q, Ye D Research (Wash D C). 2022; 2022:9891689.

PMID: 36299447 PMC: 9575473. DOI: 10.34133/2022/9891689.

References

Zhong F, Chen H, Han L, Jin Y, Wang W . Curcumin attenuates lipopolysaccharide-induced renal inflammation. Biol Pharm Bull. 2011; 34(2):226-32. DOI: 10.1248/bpb.34.226. View

Gerritsma J, van Kooten C, Gerritsen A, Mommaas A, van Es L, Daha M . Production of inflammatory mediators and cytokine responsiveness of an SV40-transformed human proximal tubular epithelial cell line. Exp Nephrol. 1998; 6(3):208-16. DOI: 10.1159/000020525. View

Yuan Y, Huang S, Wang W, Wang Y, Zhang P, Zhu C . Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int. 2012; 82(7):771-89. DOI: 10.1038/ki.2012.188. View

Wen X, Li Y, Liu Y . Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand. J Biol Chem. 2010; 285(39):29981-8. PMC: 2943317. DOI: 10.1074/jbc.M110.110908. View

DAgati V . Pathobiology of focal segmental glomerulosclerosis: new developments. Curr Opin Nephrol Hypertens. 2012; 21(3):243-50. DOI: 10.1097/MNH.0b013e32835200df. View

Rosen E, Hsu C, Wang X, Sakai S, Freeman M, Gonzalez F . C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002; 16(1):22-6. PMC: 155311. DOI: 10.1101/gad.948702. View

Panzer U, Steinmetz O, Stahl R, Wolf G . Kidney diseases and chemokines. Curr Drug Targets. 2006; 7(1):65-80. DOI: 10.2174/138945006775270213. View

Rangan G, Wang Y, Harris D . NF-kappaB signalling in chronic kidney disease. Front Biosci (Landmark Ed). 2009; 14(9):3496-522. DOI: 10.2741/3467. View

Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson B, Saito Y . A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol. 2002; 161(3):799-805. PMC: 1867262. DOI: 10.1016/S0002-9440(10)64239-3. View

10.

Murakami A, Oshiro H, Kanzaki S, Yamaguchi A, Yamanaka S, Furuya M . A novel method for isolating podocytes using magnetic activated cell sorting. Nephrol Dial Transplant. 2010; 25(12):3884-90. DOI: 10.1093/ndt/gfq323. View

11.

Radomska H, Huettner C, Zhang P, Cheng T, Scadden D, Tenen D . CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998; 18(7):4301-14. PMC: 109014. DOI: 10.1128/MCB.18.7.4301. View

12.

Lin T, Lee T, Hsu S, Yang C . The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One. 2011; 6(2):e16654. PMC: 3033396. DOI: 10.1371/journal.pone.0016654. View

13.

Friedman A . C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development. Blood Cells Mol Dis. 2007; 39(3):340-3. PMC: 2083642. DOI: 10.1016/j.bcmd.2007.06.010. View

14.

Awazu M, Omori S, Ishikura K, Hida M, Fujita H . The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol. 2003; 14(3):699-708. DOI: 10.1097/01.asn.0000051726.41601.c0. View

15.

Potapova T, Sivakumar S, Flynn J, Li R, Gorbsky G . Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell. 2011; 22(8):1191-206. PMC: 3078080. DOI: 10.1091/mbc.E10-07-0599. View

16.

Santos R, Pena Rico M, Bartrons R, Pujol F, Rosa J, Rodrigues de Oliveira J . The transcriptional activation of the cyclooxygenase-2 gene in zymosan-activated macrophages is dependent on NF-kappa B, C/EBP, AP-1, and CRE sites. Inflammation. 2010; 34(6):653-8. DOI: 10.1007/s10753-010-9275-3. View

17.

Saleem M, OHare M, Reiser J, Coward R, Inward C, Farren T . A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002; 13(3):630-638. DOI: 10.1681/ASN.V133630. View

18.

Querfurth E, Schuster M, Kulessa H, Crispino J, DODERLEIN G, Orkin S . Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. 2000; 14(19):2515-25. PMC: 316981. DOI: 10.1101/gad.177200. View

19.

Daha M, van Kooten C . Is the proximal tubular cell a proinflammatory cell?. Nephrol Dial Transplant. 2001; 15 Suppl 6:41-3. DOI: 10.1093/ndt/15.suppl_6.41. View

20.

Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus M, Dayaram T, Owens B . Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 2004; 21(6):853-63. DOI: 10.1016/j.immuni.2004.11.006. View